Extensive Menu of Validated Assays is Key to Seamless Lab Automation

Gold Standard Diagnostics, Corp. (GSD) announced today more than 200 “ThunderBolt Ready” assay protocols for Autoimmune, Oncology, Infectious Disease, Endocrinology and Cardiovascular testing from more than 20 different manufacturers, are now validated on the ThunderBolt™ EIA platform.

The term “ThunderBolt-Ready” guarantees a quick, easy and effective solution for ELISA automation needs. In order to be “ThunderBolt-Ready”, each assay protocol undergoes an industry-accepted inspection that includes correlation, linearity, precision, carryover and drift.

The ThunderBolt EIA platform is completely open and has many patented features that allow virtually any protocol to be easily and methodically validated.

GSD provides fully-validated protocols that can be used seamlessly on the ThunderBolt™ to deliver highly reliable implementations while maintaining low overall cost compared to building an automation solution from multiple manufacturers.

Any “ThunderBolt-Ready” assay can be quickly installed, and the large library of validated protocols ensures reliable performance on the ThunderBolt. GSD supports the entire laboratory solution to ensure that technical assistance for reagents and instrumentation is delivered promptly by a single point of contact.